Octave Specialty Group, Inc.
NYSE:OSGInsurance - Specialty
-$0.07 today
- Market cap
- $221.70M
- Beta
- 0.85
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$4.40
Volume 0.29M
Average 0.67M
OSG Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Octave Specialty Group, Inc.NYSE: OSG
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How OSG compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for OSG, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
TWFGTWFG, Inc. Common Stock | LTM Mar 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding OSG) | — | — | — | 0.0% | |
Competitors are the stored peer set for OSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 247M | 53.61M | 124.73M | 235.82M | 251.22M |
| Cost of Revenue | (72M) | 29.25M | 76.73M | 137.17M | 47.19M |
| Gross Profit | 319M | 24.37M | 47.99M | 98.65M | 204.03M |
| Gross Margin | 129.1% | 45.4% | 38.5% | 41.8% | 81.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 111M | 56.28M | 66.99M | 129.17M | 191.62M |
| Operating Expenses | 320M | 60.07M | 72.22M | 158.49M | 305.04M |
| Depreciation & Amortization | 57M | 3.79M | 5.23M | 19.95M | 41.95M |
| EBITDA | 246M | (31.91M) | (18.99M) | (30.52M) | (40.42M) |
| EBITDA Margin | 99.6% | -59.5% | -15.2% | -12.9% | -16.1% |
| Operating Income | (1M) | (35.71M) | (24.22M) | (59.85M) | (101.01M) |
| Operating Margin | -0.4% | -66.6% | -19.4% | -25.4% | -40.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 187M | 167M | 0 | 9.38M | 18.64M |
| Other Income / Expenses | 3M | 0 | 0 | 0 | 0 |
| Income Before Tax | 2M | (35.71M) | (24.22M) | (59.85M) | (101.01M) |
| Pre-Tax Margin | 0.8% | -66.6% | -19.4% | -25.4% | -40.2% |
| Income Tax Expense | 18M | (462K) | (989K) | (924K) | (5.21M) |
| Net Income | (17M) | 521.25M | 3.63M | (556.45M) | (240.92M) |
| Net Margin | -6.9% | 972.3% | 2.9% | -236.0% | -95.9% |
| EPS (Basic) | (0.61) | 11.48 | 0.18 | 1.42 | (5.93) |
| EPS (Diluted) | (0.61) | 11.31 | 0.18 | 1.42 | (5.93) |
| Weighted Avg Shares | 46.54M | 45.72M | 45.64M | 46.97M | 47.18M |
| Weighted Avg Shares (Diluted) | 46.54M | 46.41M | 45.64M | 46.97M | 47.18M |
Octave Specialty Group, Inc.
NYSE:OSG
Intrinsic Alpha fair value
Locked
Current Price
$4.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.